Abstract: The new regulation on pharmaceuticals, (EC) 726/2004 of the European
Parliament and of the Council of 31 March 2004 reinforces the legal basis for a
European database on medicinal products. Legislators and other stakeholders
have great expectations of this database. This paper reviews the legal base for
this database, lists other drivers for its implementation, and examines the
benefits of such a database for the different stakeholders. It describes the
scope of the database in terms of data elements, data sources, data users and
data usage. The paper discusses the current implementation plan and addresses
technical and other challenges to its successful construction and routine
use.